Share
6,018 Posts.
lightbulb Created with Sketch. 686
clock Created with Sketch. 09/01/17
20:33
Share
Originally posted by nixon
↑
G'day Gents,buy particularly at current levels. In my eyes the product is already proven - CE Mark, numerous studies, backing of prestigious Carrick Institute, alignment with Italian Red Cross / Autism Groups. We already have sales in place netting profit of ~AUD$7.5m over 3 years from a single contract with a single distributor in a single country. Not many stocks at this end of the market can boast that. The fact that we are trading at a market cap of c.$30m on these facts alone are quite astounding.strong management team with runs on the board and an scientific advisory board of the highest calibre , FDA approval looming (mere months away as oppose to some pipe dream which is years and years down the track), as well as the Mente Pro Suite providing additional market opportunity by Q4. This is looking significantly undervalued in comparison to peers. That's without even considering the potential worth of the data being collected nor the push into new categories ie. Epilepsy.100-150m market cap and fully expect NTI to reach this well within that time frame.
Expand
Thanks for your post
